Japan Tobacco 2025 H1 Financial Report: Net Profit Up 5% YoY to $2.1 Billion, Heated Tobacco Shipments Rise Nearly 30%

Aug.01.2025
Japan Tobacco 2025 H1 Financial Report: Net Profit Up 5% YoY to $2.1 Billion, Heated Tobacco Shipments Rise Nearly 30%
Japan Tobacco's (JT) 2025 H1 financial report shows year-over-year growth in key metrics, driven by pricing strategy, international business integration, and heated tobacco (HTS) expansion. Net revenue reached approximately $11.5 billion, up 10.5% YoY, while net profit rose 4.8% to about $2.1 billion. HTS shipments hit 5 billion units, a 29.5% YoY increase. The newly launched Ploom AURA reached a 13.6% market share in Japan in Q2.

Key Points:

 

Core business data

 

·Second quarter: Net revenue of 907.6 billion yen (approximately $6 billion ), up 9.4% year-on-year; net profit of 162.4 billion yen (approximately $1.1 billion), up 9.8% year-on-year; adjusted operating profit of 273.3 billion yen (approximately $1.8 billion), up a significant 20.7% year-on-year. 

 

·First half of the year: Net revenue of 1.73 trillion yen (approximately $11.5 billion), up 10.5% year-on-year; adjusted operating profit of 539.9 billion yen (approximately $3.6 billion), up 19.2% year-on-year. 

 

New Tobacco Product (HTS)

 

·In the first half of the year, shipments reached 5 billion units, a significant increase of 29.5% year-on-year. 

 

·In the Japanese market, the new device PloomAURA has tripled its sales in the three weeks since its launch, helping JT's share in the Japanese HTS market rise to 13.6% in the second quarter. 

 

International Business Performance

 

·In the EMA region (including the Americas), tobacco revenue increased by 27.9% year-on-year, with adjusted operating profit surging by 49.8%, mainly driven by the acquisition and integration of the Vector Group in the United States. 

 

·In Western Europe, sales volume decreased by 5.8%, but revenue increased by 3.5% due to pricing strategies, leading to an 8.5% increase in operating profit. 

 

·In Asia (excluding Japan), both revenue and operating profit saw steady growth, increasing by 4.6% and 4.2% respectively. 

 

Outlook for the Full Year and Shareholder Returns

 

·The full-year adjusted operating profit growth forecast has been raised to 14.6% at constant exchange rates; 

 

·Annual earnings per share has been increased from 194 Japanese yen to 208 Japanese yen (approximately $1.4), with a mid-term dividend of 104 Japanese yen (approximately $0.7).

 


[2Firsts News Flash] According to a report on the official website of Japan Tobacco on July 31, Japan Tobacco (JT) has released its financial report for the second quarter and first half of 2025. The report shows that due to strong price strategies in the tobacco business, significant acquisition and integration effects in the United States, and continuous growth of HNB products (HTS), JT has significantly raised its full-year performance guidance for 2025 and announced an increase in annual dividends.

 

 

Core Financial Performance

 

In the second quarter (April-June), growth momentum remained robust, with all key financial indicators showing steady growth.

 

·Net income: 907.6 billion yen (approximately $6 billion), an increase of 9.4% year-on-year. 

 

·Net profit: 162.4 billion yen (approximately $1.1 billion), an increase of 9.8% year-on-year. 

 

·Adjusted operating profit: 273.3 billion yen (approximately $1.8 billion), an increase of 20.7% year-on-year. 

 

 

Cumulative Performance for the First Half of the Year (January to June)

 

·Net income: The cumulative net income for the first half of the year was 1.73 trillion Japanese yen (approximately $11.5 billion), an increase of 10.5% year-on-year.

 

·Net profit: In the first half of the year, it accumulated to 319.9 billion yen (approximately $2.1 billion), an increase of 4.8% compared to the same period last year.

 

·Adjusted operating profit: The accumulated profit for the first half of the year was 539.9 billion yen (approximately $3.6 billion), a 19.2% year-on-year increase.

 

 

Performance of Business Segments (First Half of 2025)

 

Traditional tobacco

 

·Financial performance: Tobacco product revenue was 1.55 trillion yen (approximately $10.3 billion), a year-on-year increase of 11.5%. Adjusted operating profit was 556.1 billion yen (approximately $3.7 billion), a year-on-year increase of 17.8%.

 

·Sales Performance: The total shipment volume was 283.3 billion units, a year-on-year increase of 0.7%, with traditional cigarette sales remaining stable.

 

Highlights of the new Reduced-Risk Products (RRP) business

 

·HTS shows significant growth: HNB product shipments reached 5 billion units in the first half of the year, a substantial increase of 29.5% compared to the same period last year, making it the top priority investment target for the company.

 

·PloomAURA: In May, the new device PloomAURA was launched in Japan and initial sales far exceeded expectations. In the first three weeks after its release, the total sales of devices were approximately three times higher than the previous model. This successful launch helped PloomAURA to capture a market share of 13.6% in the Japanese HTS category in the second quarter.

 

International Business Performance (First Half of 2025)

 

The international business of Japan Tobacco Inc. has shown varying performances in different regions, with the mergers and acquisitions effects being particularly prominent in the Americas.

 

·The EMA (Europe, Middle East, Africa, and Americas) region showed the strongest growth. At constant exchange rates, revenue from tobacco products increased significantly by 27.9%, while adjusted operating profit soared by 49.8%. This was mainly due to the integration effects of the acquisition of Vector Group Ltd. (VGR) in the United States.

 

·Western Europe: Exhibiting the characteristics of "quantity decline, price increase." Despite a 5.8% decrease in total sales volume, under successful pricing strategies, revenue grew by 3.5% at a constant exchange rate, and adjusted operating profits increased by 8.5%.

 

·Asia region (excluding Japan market): Stable performance. With constant exchange rates, tobacco product revenue increased by 4.6%, while adjusted operating profit increased by 4.2%.

 

Future Prospects and Shareholder Returns

 

Based on its strong performance in the first half of the year, JT has significantly raised its full-year earnings outlook and increased its shareholder return plan.

 

·Revised Full-Year Guidance: The company has revised its full-year forecast for adjusted operating profit growth (at constant exchange rates) to 14.6%.

 

·Increase shareholder returns: The company has raised its annual per share dividend expectation from the previous 194 yen to 208 yen (approximately $1.4), with a mid-term dividend of 104 yen (approximately $0.7).

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China’s Vape-Related Exports Rose 4.5% in Q3 2026 as 21.6% Growth in Shipments to the UK Offset a Decline in Shipments to the US
China’s Vape-Related Exports Rose 4.5% in Q3 2026 as 21.6% Growth in Shipments to the UK Offset a Decline in Shipments to the US
China's vape-related exports rose 4.5% year over year to $2.86 billion in the third quarter of 2026, led by stronger shipments to the United Kingdom as exports to the United States declined. UK-bound shipments increased 21.6%, adding $81.9 million, while US exports fell 5.2%, or $53.6 million. Growth weakened through the quarter, with September exports down 6.3% globally and 37.8% to the US. Nicotine-containing vape products accounted for more than 82% of the quarterly net increase, while device exports were nearly flat. Nine-month exports totaled $7.82 billion, up 4.0%.
DATA
Oct.26
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
Japan Tobacco International's Irish business has proposed a €0.25 tax increase on a pack of 20 cigarettes in its pre-Budget 2027 submission, below the €0.50-or-more increases typically imposed in recent Irish budgets. JTI says the proposal could generate around €45 million in additional Exchequer revenue while limiting further movement toward illicit and non-Irish-tax-paid tobacco. Revenue's existing estimate for a comparable €0.25 increase, including pro-rata rises on other tobacco products, is about €18 million for a full year.
JTI
Sep.18 by 2Firsts Perspectives
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea's liquid-vape market is showing changes across raw-material imports, product types and sales channels after synthetic nicotine came under the Tobacco Business Act on April 24. Customs data show nicotine-analogue imports totaled 12,126 kilograms from April through August, while synthetic-nicotine imports over the same five months totaled 231,663 kilograms, just 39.3% of the amount imported in March alone. Physical liquid-vape stores tracked in Seoul and Gyeonggi Province fell 9.9%, unmanned outlets edged higher and online sales listings increased from 27,774 to 42,437. Government testing of 105 liquid inhalation products promoted as nicotine-free separately found nicotine in 13 and 6-methylnicotine in 12.
Sep.22